Entry Detail



General Information

Database ID:exR0233119
RNA Name:hsa-miR-520f-3p
RNA Type:miRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):53682213End Site(bp):53682234
External Links:hsa-miR-520f-3p



Disease Information

Disease Name:Benign bone and soft tissue tumor
Disease Category:Other Diseases
MeSH ID:
Type:
Alias:



Expression Detail

GEO ID:GSE124158
Description:A serum miRNA classifier diagnoses bone and soft tissue sarcomas across various histological subtypes
Experimental Design:Cancer vs Control
Case Disease Type:Benign bone and soft tissue tumor
Case Disease SubType:NA
Case Sample:Benign bone and soft tissue tumor
Control Sample:Healthy
Number of Case:339
Number of Control:275
Number of Samples:614





Regulatory Relationship

mRNA targets:NA
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000384
chr12
27867712
27877119
+
hsa_circ_0001723
chr7
91924202
91948826
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
NEAT1
chr11
65422774
65445540
+
SNHG1
chr11
62851984
62855953
-
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE124158
Sample Source:Blood
Source Fraction:Serum
Platform:GPL21263
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2512
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.).
RNA library preparation protocol:miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.



Reference

PMID:30898996
Title:A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes
Author:Asano N, Matsuzaki J, Ichikawa M, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Yoshida A, Kobayashi E, Tanzawa Y, Nakayama R, Morioka H, Matsumoto M, Nakamura M, Kondo T, Kato K, Tsuchiya N, Kawai A, Ochiya T
Journal:Nat Commun. 2019 Mar 21;10(1):1299.
Description:we investigated serum miRNA profiles from 1002 patientswith bone and soft tissue tumors representing more than 43 histological subtypes,including sarcomas, intermediate tumors, and benign tumors, to determine whether serum miRNA profiles could be used to specifically detect sarcomas.